Recent

% | $
Quotes you view appear here for quick access.

OXiGENE, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • edteekay edteekay Jul 16, 2008 4:20 PM Flag

    New abstract - ATC phase II trial

    Yes, I was mistaken on the combo therapy, but after the dismal failure of the mono therapy, I see no reason to be terribly sanguine about a combo therapy. What ever value this company may have I doubt it lies in an ATC treatment. I suspect management feels the same way and that's why they subsequently launched a fuselade of new trials.

 
OXGN
1.390.00(0.00%)May 1 4:00 PMEDT